Add like
Add dislike
Add to saved papers

MOV10 sequesters the RNP of influenza A virus in the cytoplasm and is antagonized by viral NS1 protein.

Biochemical Journal 2019 January 8
MOV10 has emerged as an important host antiviral factor. MOV10 not only inhibits various viruses including human immunodeficiency virus type 1, hepatitis C virus and vesicular stomatitis virus, it also restricts the activity of retroelements LINE-1, Alu, SVA and IAP. Here we report that MOV10 suppresses influenza A virus infection through interacting with viral nucleoprotein, sequestering viral RNP in the cytoplasm and causing the degradation of viral vRNA. This antiviral activity of MOV10 depends on the integrity of P-bodies. We also found that the antiviral activity of MOV10 is partially countered by viral NS1 protein that interferes with the interaction of MOV10 with viral nucleoprotein and causes MOV10 degradation through the lysosomal pathway. Moreover, NS1 defective IAV is more susceptible to MOV10 restriction. Our data not only expand the antiviral spectrum of MOV10, but more importantly reveal the NS1 protein as the first viral antagonist of MOV10.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app